PRESS RELEASE, MIAMI, FLA. : Dr. George M. Suarez, Founder of Suarez Urology, a Miami based urology practice specializing in the diagnosis, and minimally invasive treatment of localized prostate cancer with High Intensity Focused Ultrasound (HIFU) therapy, is now providing the most advanced diagnostic tools for the precise and accurate diagnosis and treatment of localized prostate cancer by utilizing a newly developed FDA approved technology. The sophisticated combination of multi parametric-MRI with the fusion of ultrasound images provides superior capabilities for early diagnosis of prostate cancer never available before. Dr. Suarez noted that Suarez Urology is the first clinical practice to incorporate multi-parametric MRI, as well as both transrectal and transperineal biopsy capability in the United States.
The principle advantage of the combined technologies allows the ability to offer focal and hemi-ablation HIFU treatment in properly selected patients. As well as plan for optimal whole gland potency sparring HIFU treatment. The combined fused imaging studies are then incorporated into the Sonablate HIFU “Smart Target™” treatment plan with the ability to limit treatment to the cancer areas, and not affecting the healthy non-malignant tissue.
Dr. Suarez stated: “We are also getting ready to go live on our previously registered website, www.malelumpectomy.com, a domain we registered over 10 years ago in anticipation of the future of where prostate cancer treatment was headed. This MRI-Ultrasound fusion technology has been available outside the United States for some time, and many urologists feel this medical break-through of improved diagnostics and focal HIFU therapy will be the new standard for diagnosis and treatment of localized prostate cancer. In many ways this resembles the evolution that occurred in the diagnosis and treatment of breast cancer when blind breast biopsies were followed by radical surgery (mastectomy) and extended axillary lymph node dissection. Resulting in the physical, emotional and psychological compromise to the patient and their families. Image guided biopsy, mammography and lumpectomy progressed to a treatment that today offers true tissue sparring therapy for women with breast cancer. We are equally optimistic that we are in position to provide similar alternative for men with prostate cancer.”
As founder and medical director emeritus of SonaCare, formerly USHIFU/International HIFU, Dr. Suarez, brings huge expertise in the application for MRI-ultrasound fusion diagnostic capability and the potential of focal “Smart Target” HIFU therapy.
In addition to prostate “GPS Guided” biopsy capability and greater sensitivity and specificity for sampling the suspicious regions of interest, this technology will also decrease the need of unnecessary biopsy sampling, as well as unnecessary treatment beyond the diseased area.
CONCLUSIVE ADVANTAGES OF MULTIPARAMETRIC PARAMETRIC-MRI ULTRASOUND FUSED PROSTATE GUIDED BIOPSY
Incorporating the following features and advantages over existing, mostly blind biopsy sampling and treatment, image-guided biopsies provides the following imaging enhancements to standard 2-Dimensional ultrasound. The “Smart Target” Sonablate HIFU treatment allows for precision treatment limited to the cancer cells.
- Automatically converts a 2-Dimensional ultrasound image to an enhanced 3-Dimensional image can be manipulated to plan and manage the patient biopsy process.
- Greatly increases the ability to examine the prostate for abnormalities or suspicious areas or regions of interest (ROI) which may need sampling.
- Advanced needle navigation and tracking with the capability to view in real-time.
- Sophisticated recording of actual biopsy sites sampled; sites can be revisited at any time if additional biopsies are necessary.
- The ability to view and overlay previous prostate gland volumes and biopsy locations.
- Accurately assists you in the tracking and management of prostate cancer.
“SMART TARGET ™” HIFU TREATMENT
The “Smart Target HIFU™” treatment utilizes a unique software to incorporate the multi-parametric-transrectal ultrasound fused images onto the Sonablate HIFU equipment. This allows the urologist to perform precision image guided “Smart Target™” treatment of the cancer cells while avoiding unnecessary toxicity to the non-cancerous cells. Thereby, minimizing potential side effects or collateral damage healthy tissue and vital structures responsible for preserving urinary continence and sexual potency.
“The break through of image guided precision in the diagnosis and treatment of prostate cancer will have huge impact on the way we treat the most common cancer in men, the second most cause of cancer related deaths and as well as provide an alternative therapy with less side effects, complications or collateral damage to quality of life issues common with other treatments.” Stated Dr. George Suarez.
For additional inquiries, please refer to the contact information below:
George M. Suarez, M.D., F.A.C.S.
Founder, Medical Director Emeritus,
US HIFU, International HIFU
Office information: 9195 Sunset Drive, Suite 110
Miami, Fla. 33173
Toll free: 1-877-9795325 or 1-877-why-leak